Clinical & Pharma

Asia-Pacific Nations Modernize Healthcare Regulations
Clinical & Pharma Asia-Pacific Nations Modernize Healthcare Regulations

Australian regulators have reassigned saline-only vascular access locking solutions to Class IIa status to ensure these devices meet modern safety expectations. This specific adjustment reflects a much broader wave of regulatory transformation sweeping across the Asia-Pacific region as nations

Are Flu Vaccine Success Rates Based on Flawed Data?
Clinical & Pharma Are Flu Vaccine Success Rates Based on Flawed Data?

By mislabeling patients who develop symptoms shortly after their appointment, researchers risk presenting a sanitized and inaccurate view of medical efficacy. For decades, the seasonal flu shot has been heralded as the primary defense against respiratory illness, yet a growing body of evidence

Indoor Mold Linked to Childhood Asthma After Superstorm Sandy
Clinical & Pharma Indoor Mold Linked to Childhood Asthma After Superstorm Sandy

Clinicians are encouraged to examine environmental histories more closely when a child's asthma control deteriorates following an extreme weather event. The aftermath of Superstorm Sandy in New York City revealed that the true impact of a natural disaster extends far beyond immediate structural

How Is AI Transforming the Future of Veterinary Medicine?
Clinical & Pharma How Is AI Transforming the Future of Veterinary Medicine?

Machine learning applications in veterinary medicine are transitioning from experimental concepts to practical tools for identifying canine mast cell tumors. This evolution is prominently displayed through the 19th annual Summer Veterinary Student Research Program at the Virginia-Maryland College

Global Health Trends: Flu Vaccines, Ebola, and New Diagnostics
Clinical & Pharma Global Health Trends: Flu Vaccines, Ebola, and New Diagnostics

The 2024-2025 influenza season in the United States reached a level of severity not witnessed since 2017, placing an unprecedented strain on the nation's healthcare infrastructure. This period of high viral circulation highlighted the urgent necessity of integrating real-world data with clinical

Sutter Health Launches New CAR T Therapy Trial for Lymphoma
Clinical & Pharma Sutter Health Launches New CAR T Therapy Trial for Lymphoma

Sutter Health’s new clinical trial specifically addresses the gap in care for lymphoma patients who are in remission but still harbor lingering cancer cells in their bloodstream. This condition, known as minimal residual disease, often serves as a silent precursor to full-scale relapse, creating a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later